The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Moore Matthew Richard since 2023.
This trader's CIK number is 1840191.
At the time of last reporting, Moore Matthew Richard was the SVP and Chief Business Officer of Arcutis Biotherapeutics, Inc.. (stock ticker symbol ARQT).
Also see all insider trading activities at Arcutis Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ARQT | 0 | $0 | 4,681 | $40,902 | 0 | $0 |
| 2023 | ARQT | 0 | $0 | 1,610 | $26,032 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-02 | ARQT | Sale | 4,681 | 8.74 | 40,902 |
| 2023-03-02 | ARQT | Sale | 1,610 | 16.17 | 26,032 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Moore Matthew Richard (SVP and Chief Business Officer of Arcutis Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.